There are 2789 resources available
LBA38 - Bexmarilimab, a novel macrophage re-programmer shows promising anti-tumour activity in phase I/II trial in several last line solid tumour types
Presenter: Petri Bono
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
957O - Long-term follow-up of patients (pts) with human papillomavirus (HPV)–associated malignancies treated with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1
Presenter: James Gulley
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
958O - Coordinated activation of antitumor responses of g9d2 and CD8 T-cells by targeting BTN3A with ICT01 in patients with solid tumors: EVICTION trial
Presenter: Aurélien Marabelle
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
959O - Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors
Presenter: David S. Hong
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
LBA11 - Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer
Presenter: Helena Earl
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
117O - Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: A meta-analysis of randomised trials
Presenter: Valentina Guarneri
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
118O - Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: A randomised, phase III trial of the Gruppo Italiano Mammella
Presenter: Lucia Del Mastro
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA23 - EPIK-P1: Retrospective chart review study of patients (pts) with <italic>PIK3CA</italic>-related Overgrowth Spectrum (PROS) who have received alpelisib (ALP) as part of a compassionate use programme
Presenter: Guillaume Canaud
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
512O - Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies
Presenter: Rahul Aggarwal
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
513O - A phase I/II multicenter, first-in-human study of DS-7300 (B7-H3 DXd-ADC) in patients (pts) with advanced solid tumors
Presenter: Melissa Johnson
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast